Octave Specialty Group

OSG · NYSE

$4.75+$0.13 (+2.81%)TodayMarket closed ·
Prev close $4.62

About OSG

Octave Specialty Group, Inc. is a holding company, which engages in the provision of financial guarantee insurance policies through its subsidiary, Ambac Assurance Corp. Its services include credit, insurance, asset management and other financial services. The company is headquartered in New York City, New York and currently employs 275 full-time employees. The company provides strategic direction, risk oversight, data and technology solutions, and capital support to MGA businesses operating across the U.S., U.K., and Bermuda. Its build-and-buy strategy is executed by its incubation division, Octave Ventures, and its acquisition division, Octave Partners. At Octave Ventures, it helps specialty underwriters to set up their own company, leveraging its resources. The company offers funding, infrastructure, risk capital, and A+ rated paper as well as experienced guidance and support to underwriters looking to launch their own MGAs. Octave Partners identifies high-performing MGAs that would benefit from its partnership and add value to its expanding portfolio. To facilitate growth, it provides expertise, technology, distribution and capacity relationships, expansion and cross-company sales opportunities.

Employees
275
Headquarters
New York City, New York
Listed
Jul 10, 1991
Sector
Financials
Industry
Insurance

OSG key statistics

Market cap
208.14M
Price-earnings ratio
0.00
Dividend yield
—
Average volume
493.23K
Volume
205.32K
Open price
$4.63
High today
$4.76
Low today
$4.63
52 Week high
$10.38
52 Week low
$3.88

Octave Specialty Group (OSG) at a glance

Octave Specialty Group (OSG) last traded at $4.75, with a market cap of 208.14M and a price-to-earnings ratio of 0.00.

Today the stock has traded between $4.63 and $4.76. The current price is 2.6% above the day's low and 0.2% below its high.

Volume so far is 205.32K shares, below the average of 493.23K shares a day.

Over the past year Octave Specialty Group has ranged from $3.88 to $10.38, and now sits 13% of the way up that range.

Octave Specialty Group met or beat analyst EPS estimates in 4 of the last 8 quarters. In Q2 FY26 it reported -$0.04 per share against an estimate of -$0.0051.

OSG earnings

Earnings per share, reported against the analyst estimate

Beat the estimate in 4 of the last 8 quarters, by 610.8% on average.

  1. Q3 FY24: reported -$0.46 per share against an estimate of $0.0842
  2. Q4 FY24: reported -$0.12 per share against an estimate of $0.00
  3. Q1 FY25: reported -$0.13 per share against an estimate of -$0.0707
  4. Q2 FY25: reported -$0.22 per share against an estimate of -$0.2424
  5. Q3 FY25: reported -$0.21 per share against an estimate of -$0.2323
  6. Q4 FY25: reported -$0.02 per share against an estimate of -$0.2071
  7. Q1 FY26: reported $0.37 per share against an estimate of $0.0152
  8. Q2 FY26: reported -$0.04 per share against an estimate of -$0.0051

OSG news

  • Press releaseBusiness Wire

    Octave Specialty Group to Release Third Quarter 2026 Results on November 9, 2026

  • Press releaseBusiness Wire

    Pivix Launches Monoline Commercial Property Program

  • Press releaseBusiness Wire

    E&S MGA Pivix Launches Assault & Battery Program

  • Press releaseBusiness Wire

    Octave Specialty Group Appoints Philip Stefano Head of Investor Relations

  • Press releaseBusiness Wire

    AM Best Affirms Credit Ratings of Everspan Indemnity Insurance Company and Its Affiliates

  • Press releaseBusiness Wire

    Octave Specialty Group Reports Second Quarter 2026 Results

  • Press releaseBusiness Wire

    Everspan Group Expands Leadership Team with Three Senior Appointments

  • Press releaseBusiness Wire

    Octave Specialty Group to Release Second Quarter 2026 Results on August 6, 2026

Similar companies

Companies in the same industry as Octave Specialty Group

Most active stocks

Highest trading volume today

Newly listed

Companies that went public in the past six weeks

Information on this page is provided for informational purposes only and is not a recommendation to buy, sell or hold any security. Investing involves risk, including possible loss of principal. Market data is delayed at least 15 minutes and is provided without warranty. Analyst ratings, price targets and company data come from third-party sources. Past performance does not guarantee future results.